Medical Marijuana ProCon.org HOME | CLOSE

1. Name: John P. Zajicek, Ph.D.
2. Title: Professor of Clinical Neuroscience, Neurology Research and Clinical Trials Unit, Peninsula Medical School, University of Plymouth, UK
3. Medical Marijuana
Position:		 Neutral to the question "Should marijuana be a medical option?"
4. Reasoning:

"I very much welcome any potential change to the law, providing the results of the clinical trials are positive. Some patients have already reported an improvement in pain but it is too early to draw any conclusions...

If we are to provide the evidence that the drug is useful in alleviating pain in MS then there has to be a way of getting the drug to those patients. Changes in the classification of cannabis would help for that to be achieved and that is a good thing."
 ("Medicinal Cannabis Set to be Legalised" 10/23/01)
5. Credibility
Ranking:

Experts
PhD's and JD's (lawyers) with significant post-doctoral involvement in medical marijuana issues; judges who have presided over medical marijuana cases

6. Involvement:
  • Professor of Clinical Neuroscience, Neurology Research and Clinical Trials Unit, Peninsula Medical School, University of Plymouth, UK
  • Consultant Neurologist, Derriford Hospital, Plymouth, UK
  • Principle Investigator, Cannabinoids in Multiple Sclerosis (CAMS)
  • Principle Investigator, South West Impact of Multiple Sclerosis (SWIMS)
7. Education:
  • Ph.D., school unknown
  • Fellowship of the Royal College of Physicians (FRCP)
8. Relevant Affiliations/Honors:
  • None listed
9. Contact Info:
Phone: 01752 777111 x 54376 Fax: None listed
E-Mail:   john.zajicek@phnt.swest.nhs.uk
Web Site: www.plymouth.ac.uk/pages/dynamic.asp?page=staffdetails&id=jzajicekr
10. Other: Select Publications:
  • Co-author, "The Effect of Cannabis on Urge Incontinence in Patients with Multiple Sclerosis: A Multicentre, Randomised Placebo-controlled Trial," International Urogynecology Journal and Pelvic Floor Dysfunction 2006, 17(6): 636-41
  • Co-author, "The Use of Cannabinoids in Multiple Sclerosis," Expert Opinion on Investigational Drugs 2005, 14(7): 859-69
  • Co-author, "Cannabinoid Influence on Cytokine Profile in Multiple Sclerosis," Clinical and Experimental Immunology 2005, 140(3): 580-5
  • Co-author, "The Effect of Cannabis on Tremor in Patients with Multiple Sclerosis," Neurology 2004, 62(7): 1105-9
HOME | CLOSE